Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |